Center for Clinical and Basic Research A/S: Financial statements 2013
CVR: 21142743
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Center for Clinical and Basic Research A/S (CVR 21142743) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 8,573,000 and a net result of DKK 39,179,000. The profit margin was 457%. Equity in the 2013 report amounted to DKK 170,756,000. The solvency ratio was 29.2%. The company had 7 employees in the financial year.
- Revenue
- DKK 8,573,000
- Gross Profit
- DKK 6,140,000
- Profit/Loss
- DKK 39,179,000
- Equity
- DKK 170,756,000
- Total Assets
- DKK 585,625,000
- Employees
- 7
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
Center for Clinical and Basic Research A/S has published its annual report for 2012.
As of March 22, 2013, Hans Christian Hoeck has joined the board of directors of Center for Clinical and Basic Research A/S.
As of March 22, 2013, Thomas Nielsen has left the board of directors of Center for Clinical and Basic Research A/S.
About Center for Clinical and Basic Research A/S
Center for Clinical and Basic Research A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYNARC A/S and DODONA A/S. The management consists of Victor Richard Lopes. The board consists of Petrus Thomas Adrianus van der Zande (chair), Julia Lauren Chen and Victor Richard Lopes. The company is owned by Synexus Compass, Inc.. The company has 1 employee (2024). In 2025, the company reported revenue of DKK 2,133,368 and a net result of DKK -7,411,708 compared with DKK 10,625,435 the year before. Equity in the 2025 report amounted to DKK -16,371,637.